Why use everolimus instead of tacrolimus?

To spare the kidneys: everolimus doesn't cause calcineurin-type nephrotoxicity, so regimens swap it in — often alongside reduced tacrolimus — to protect graft function over the long term.

Does everolimus cause mouth sores?

Mouth ulcers are its most common side effect — often dose-related and manageable with dose adjustment and mouth care. Report them rather than tolerating them.

Is everolimus used for anything besides transplant?

Yes — it's an approved cancer therapy (including kidney cancer). The transplant dose and cancer dose differ substantially, and the contexts shouldn't be mixed.

mTOR inhibitor (immunosuppressant)

Everolimus and Kidneys

Brand names: Zortress / Afinitor • Drug class: mTOR inhibitor (immunosuppressant)

Everolimus is an mTOR inhibitor used in kidney transplant to 'spare' the kidneys: it suppresses immune-cell growth without the direct kidney toxicity of calcineurin inhibitors, so regimens use it (often with reduced tacrolimus) to protect long-term graft function.

How it affects the kidneys

Everolimus blocks mTOR — a growth-signaling hub — suppressing immune expansion while avoiding calcineurin-type nephrotoxicity. It is used in calcineurin-sparing protocols (reduced tacrolimus or early CNI withdrawal) and can cause proteinuria and edema of its own, so kidney and urine monitoring continue.

Evidence at a glance

mTOR-inhibitor regimens with reduced calcineurin inhibitors preserve graft function with lower CNI exposure

mTOR transplant trials (e.g., TRANSFORM), 2010s

Delayed wound healing and mouth ulcers are the main tolerability limits; dosing is held around surgery

mTOR inhibitor literature, 2010s

Proteinuria and edema can occur — urine monitoring is part of follow-up

mTOR inhibitor safety data, 2010s

Renal dosing guidance

Dosed twice daily with trough-level and blood-count monitoring. Doses are held or timed around surgery (wound healing), and reduced when combined with tacrolimus.

Check your kidney function

Key warnings

Mouth ulcers — common, often dose-related
Delayed wound healing — dosing is timed around surgery
High cholesterol and triglycerides — lipids monitored
Proteinuria and edema
Grapefruit raises levels — avoid
Rare but serious: pneumonitis

Sources

Zortress prescribing information
TRANSFORM trial
mTOR inhibitor safety literature

This page is educational. Medication decisions — especially dosing changes — must be made by your prescribing clinician.

Everolimus: Common Questions

Medications & Kidney Dosing

Drug dosing by kidney function Metformin eligibility checker NSAIDs & kidneys All drug guides

Related Drugs & Kidneys

Semaglutide (Ozempic, Wegovy) and Kidneys

Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity. The FLOW trial (NEJM 2024) showe…

Learn more

SGLT2 Inhibitors (Dapagliflozin, Empagliflozin) and Kidneys

SGLT2 inhibitors — originally diabetes drugs — are now a cornerstone of kidney disease treatment. DAPA-CKD and…

Learn more

Dapagliflozin (Farxiga/Forxiga) and Kidneys

Dapagliflozin is the first SGLT2 inhibitor proven to protect kidneys in CKD with and without diabetes (DAPA-CK…

Learn more

Empagliflozin (Jardiance) and Kidneys

Empagliflozin is an SGLT2 inhibitor approved for CKD with albuminuria (eGFR ≥20) and heart failure. The EMPA-K…

Learn more

mTOR inhibitor (immunosuppressant)

Everolimus and Kidneys

Brand names: Zortress / Afinitor • Drug class: mTOR inhibitor (immunosuppressant)

How it affects the kidneys

Evidence at a glance

mTOR-inhibitor regimens with reduced calcineurin inhibitors preserve graft function with lower CNI exposure

mTOR transplant trials (e.g., TRANSFORM), 2010s

Delayed wound healing and mouth ulcers are the main tolerability limits; dosing is held around surgery

mTOR inhibitor literature, 2010s

Proteinuria and edema can occur — urine monitoring is part of follow-up

mTOR inhibitor safety data, 2010s

Renal dosing guidance

Dosed twice daily with trough-level and blood-count monitoring. Doses are held or timed around surgery (wound healing), and reduced when combined with tacrolimus.

Check your kidney function

Key warnings

Mouth ulcers — common, often dose-related
Delayed wound healing — dosing is timed around surgery
High cholesterol and triglycerides — lipids monitored
Proteinuria and edema
Grapefruit raises levels — avoid
Rare but serious: pneumonitis

Sources

Zortress prescribing information
TRANSFORM trial
mTOR inhibitor safety literature

This page is educational. Medication decisions — especially dosing changes — must be made by your prescribing clinician.

Everolimus: Common Questions

Medications & Kidney Dosing

Drug dosing by kidney function Metformin eligibility checker NSAIDs & kidneys All drug guides